<DOC>
	<DOCNO>NCT02492516</DOCNO>
	<brief_summary>Amyotrophic lateral sclerosis ( ALS ) lethal degenerative disorder upper motor lower motor neuron destroy brain stem spinal cord . Riluzole therapeutic option . Recently several study show stem cell transplantation safe effective reduction disease progression increase quality life .</brief_summary>
	<brief_title>Intravenous Injection Adipose Derived Mesenchymal Stem Cell ALS</brief_title>
	<detailed_description>study perform 8 patient sporadic form ALS ( ALS-Functional Rating Test ) ALS-FRS &gt; 24 ( Forced Vital Capacity ) FVC &gt; 40 % . The adipose sample provide healthy donor abdominal lipoaspiration . After isolation culture mesenchymal stem cell , cell inject intravenously ( 2 million cells/kg ) . All patient follow 12 month 72hours , 2months , 4 month , 6 month 12 month transplantation find adverse event . During follow assessment include : ALS-FRS , FVC electromyography serologic test .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Both gender Age : 1855 Sporadic form disease ALSFRS &gt; = 24 FVC &gt; = 40 % Familial form ALS Malignancy Autoimmune disease Diagnosis motor neuron disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>adipose tissue mesenchymal stem cell intravenous injection ALS</keyword>
</DOC>